Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement - Poll - MDSpire

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement

  • By

  • Milda Mikalonytė

  • Vilhelmas Landsbergis

  • Lukas Kevličius

  • Skirmantė Černauskienė

  • Linas Davainis

  • Andrius Žučenka

  • Igoris Trociukas

  • Regina Pileckytė

  • Birutė Davainienė

  • Inga Šlepikienė

  • Gintarė Ražanskienė

  • Ugnius Mickys

  • Jonas Ražanskas

  • Jūratė Dementavičienė

  • Mindaugas Stoškus

  • Raminta Batiuškaitė

  • Laimonas Griškevičius

  • June 9, 2026

  • 0 min

Share

Original Source(s)

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement

  • by Milda Mikalonytė, Vilhelmas Landsbergis, Lukas Kevličius, Skirmantė Černauskienė, Linas Davainis, Andrius Žučenka, Igoris Trociukas, Regina Pileckytė, Birutė Davainienė, Inga Šlepikienė, Gintarė Ražanskienė, Ugnius Mickys, Jonas Ražanskas, Jūratė Dementavičienė, Mindaugas Stoškus, Raminta Batiuškaitė, Laimonas Griškevičius

  • June 9, 2026

Related Content

First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study

Cross-attention guided multi-modal network for breast ultrasound diagnosis incorporating objective clinical semantics

Case Report: a rare case of small cell carcinoma of the prostate